Nanobac Pharmaceuticals, Incorporated (NNBP)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -910.88 Thousand | -2.58 Million | -2.36 Million | -3.39 Million | -2.15 Million | -1.06 Million |
| Net Income | -6.57 Million | -4.97 Million | -3.68 Million | -7.87 Million | -3.69 Million | -1.47 Million |
| Depreciation & Amortization | 460.3 Thousand | 541.27 Thousand | 759.93 Thousand | 717.07 Thousand | 181.1 Thousand | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.75 Million | 339.01 Thousand | -235.54 Thousand | 961.25 Thousand | 578.77 Thousand | 346.14 Thousand |
| Other non-cash items | 3.45 Million | 1.48 Million | - | - | - | 59.48 Thousand |
| Investing Cash Flow | 48.56 Thousand | -15.49 Thousand | -40.63 Thousand | 164.83 Thousand | 197.88 Thousand | - |
| Investments in PPE | -1533.00 | -12.75 Thousand | -40.63 Thousand | -36.76 Thousand | -18.15 Thousand | - |
| Acquisitions | - | - | - | -901.00 | -81.02 Thousand | - |
| Investment purchases | - | - | - | - | -2932.00 | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 50.1 Thousand | -2731.00 | - | 202.5 Thousand | 300 Thousand | - |
| Financing Cash Flow | 910.88 Thousand | 2.68 Million | 2.32 Million | 3.21 Million | 2.02 Million | 1.06 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 200 Thousand | 1.17 Million | 548 Thousand | 1.05 Million |
| Other Financing Activities | - | - | -35.64 Thousand | - | - | 18 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 56.04 Thousand | 50.92 Thousand | -46.7 Thousand | -54.36 Thousand | 67.28 Thousand | - |
| Other working capital | 5282.00 | 39.66 Thousand | - | - | 78.38 Thousand | 5223.00 |
| Cash at beginning of period | 39.5 Thousand | 8975.00 | 17.9 Thousand | 49.75 Thousand | - | - |
| Cash at end of period | 3933.00 | 39.5 Thousand | 8975.00 | 17.9 Thousand | 49.75 Thousand | - |
| Capital Expenditure | -1533.00 | -12.75 Thousand | -40.63 Thousand | -36.76 Thousand | -18.15 Thousand | - |
| Effect of forex changes on cash | -84.13 Thousand | -58.04 Thousand | 70.89 Thousand | -16.9 Thousand | -15.63 Thousand | - |
| Net cash flow / Change in cash | -35.57 Thousand | 30.53 Thousand | -8933.00 | -31.84 Thousand | 49.75 Thousand | - |
| Free Cash Flow | -912.41 Thousand | -2.59 Million | -2.4 Million | -3.43 Million | -2.17 Million | -1.06 Million |
| Breakdown | 2007 Q4 | 2007 FY | 2007 Q3 | 2007 Q2 | 2007 Q1 | 2006 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.16 Million | -6.57 Million | -835.76 Thousand | -716.56 Thousand | -3.85 Million | -4.97 Million |
| Depreciation & Amortization | 113.81 Thousand | 460.3 Thousand | 114.55 Thousand | 115.28 Thousand | 116.64 Thousand | 541.27 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 741.6 Thousand | 1.75 Million | 177.77 Thousand | 272.76 Thousand | 558.91 Thousand | 339.01 Thousand |
| Other non-cash items | 336.53 Thousand | 3.45 Million | 1.46 Million | -1.21 Million | 2.86 Million | 1.48 Million |
| Investing Cash Flow | -301.00 | 48.56 Thousand | -3221.00 | - | 52.08 Thousand | -15.49 Thousand |
| Investments in PPE | -1.00 | -1533.00 | - | - | -1532.00 | -12.75 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -300.00 | 50.1 Thousand | - | - | 50.4 Thousand | -2731.00 |
| Financing Cash Flow | 157.57 Thousand | 910.88 Thousand | 241.04 Thousand | 274.47 Thousand | 237.78 Thousand | 2.68 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -320.00 | 56.04 Thousand | 57.78 Thousand | -705.00 | -708.00 | 50.92 Thousand |
| Other working capital | 12.93 Thousand | 5282.00 | 35.21 Thousand | -37.7 Thousand | -5157.00 | 39.66 Thousand |
| Cash at beginning of period | 661.00 | 39.5 Thousand | 967.00 | 6231.00 | 39.5 Thousand | 8975.00 |
| Cash at end of period | 3933.00 | 3933.00 | 661.00 | 967.00 | 6231.00 | 39.5 Thousand |
| Capital Expenditure | -1.00 | -1533.00 | - | - | -1532.00 | -12.75 Thousand |
| Effect of forex changes on cash | -43.68 Thousand | -84.13 Thousand | -37.85 Thousand | 5337.00 | -7937.00 | -58.04 Thousand |
| Net cash flow / Change in cash | 3272.00 | -35.57 Thousand | -306.00 | -5264.00 | -33.27 Thousand | 30.53 Thousand |
| Free Cash Flow | -110.31 Thousand | -912.41 Thousand | -200.28 Thousand | -285.07 Thousand | -316.74 Thousand | -2.59 Million |
0228
7531
OCEA
WBX
AETHER
BNS